Additionally, the 36-month beta value for HSCS is 3.15. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for HSCS is 0.73M and currently, short sellers hold a 5.44% ratio of that float. The average trading volume of HSCS on September 12, 2024 was 58.55K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
HSCS) stock’s latest price update
Heart Test Laboratories Inc. (NASDAQ: HSCS)’s stock price has dropped by -1.77 in relation to previous closing price of 2.82. Nevertheless, the company has seen a loss of -13.98% in its stock price over the last five trading days. globenewswire.com reported 2024-09-12 that Southlake, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced the close of a non-dilutive financing, with $1.9 million in net proceeds. The unsecured loan note has an 18-month maturity date and follows the recent 12-month extension of a $500,000 loan note to September 2025.
HSCS’s Market Performance
Heart Test Laboratories Inc. (HSCS) has experienced a -13.98% fall in stock performance for the past week, with a -15.55% drop in the past month, and a -47.74% drop in the past quarter. The volatility ratio for the week is 11.36%, and the volatility levels for the past 30 days are at 9.26% for HSCS. The simple moving average for the past 20 days is -15.11% for HSCS’s stock, with a -71.61% simple moving average for the past 200 days.
HSCS Trading at -23.94% from the 50-Day Moving Average
After a stumble in the market that brought HSCS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -96.75% of loss for the given period.
Volatility was left at 9.26%, however, over the last 30 days, the volatility rate increased by 11.36%, as shares sank -14.73% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -45.50% lower at present.
During the last 5 trading sessions, HSCS fell by -11.82%, which changed the moving average for the period of 200-days by -87.44% in comparison to the 20-day moving average, which settled at $3.24. In addition, Heart Test Laboratories Inc. saw -83.80% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for HSCS
Current profitability levels for the company are sitting at:
- -339.02 for the present operating margin
- -0.42 for the gross margin
The net margin for Heart Test Laboratories Inc. stands at -355.12. The total capital return value is set at -0.81. Equity return is now at value -175.02, with -103.28 for asset returns.
Based on Heart Test Laboratories Inc. (HSCS), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at -5.86. The debt to equity ratio resting at 0.14. The interest coverage ratio of the stock is -17.81.
Currently, EBITDA for the company is -6.31 million with net debt to EBITDA at 0.78. When we switch over and look at the enterprise to sales, we see a ratio of -127.67. The receivables turnover for the company is 0.02for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.80.
Conclusion
In conclusion, Heart Test Laboratories Inc. (HSCS) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
